This is a review paper which focuses on clinical and practical challenges associated with the Covid-19 epidemic and the impact on drug treatment.
A starting point is the fact that persons with substance use disorders often are vulnerable, and that this vulnerability is intensified during the current epidemic and the added risk of acute respiratory infection.
The paper contributes with general advice regarding the treatment of substance use disorders both for treatment providers and for treatment systems managers.
The goal of the paper is to contribute towards improved patient services and reduce virus transmission both for patients and treatment providers.
Review Paper: COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper